Fevipiprant

DB12011InvestigationalSmall molecule

Fevipiprant has been used in trials studying the treatment of Asthma, Atopic Dermatitis, and Allergic Rhinitis.

Mechanism: Pharmacologically active on Prostaglandin D2 receptor 2
Curator reviewed
Formula / weight: C₁₉H₁₇F₃N₂O₄S · 426.41 g/mol (avg)
Code names: QAW-039

Resolves to

Compound

Structure

InChIKeyGFPPXZDRVCSVNR-UHFFFAOYSA-NSMILESCC1=C(CC(O)=O)C2=CC=CN=C2N1CC1=CC=C(C=C1C(F)(F)F)S(C)(=O)=O

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

12Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Fevipiprant, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.